San Diego, CA, United States of America

Antonino Catanzaro

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Antonino Catanzaro: Innovator in Pathogen Detection

Introduction

Antonino Catanzaro is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pathogen detection, holding 2 patents that showcase his innovative approaches. His work focuses on improving methods for identifying drug-resistant pathogens, which is crucial for public health.

Latest Patents

One of Antonino Catanzaro's latest patents is titled "Single molecule-overlapping read analysis for minor variant mutation detection in pathogen samples." This invention provides a method for detecting a heteroresistant population of a pathogen in a sample. The method involves several steps, including extracting nucleic acids from the sample, amplifying a target locus of the pathogen's genome, and sequencing overlapping nucleic acid strands from a single DNA molecule. An alignment algorithm is then applied to the sequencing data to analyze and detect minor variants associated with drug resistance.

Career Highlights

Throughout his career, Antonino has worked with esteemed organizations such as the Translational Genomics Research Institute and Northern Arizona University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Antonino's notable coworkers include Rebecca E. Colman and David Engelthaler. Their collaborative efforts have further advanced the research and development of innovative solutions in pathogen detection.

Conclusion

Antonino Catanzaro's work in pathogen detection exemplifies the importance of innovation in addressing public health challenges. His patents and collaborations reflect a commitment to advancing scientific knowledge and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…